Release Date: 28/09/12 12:45 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 1.66MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%